Monday, November 30, 2015 10:00:06 AM
While I have crossed-over the "figuring it out" stage at least regarding near-term investment.
As you mentioned, nothing about this company is unusual at this stage and as such, it will need a close look at the cash-burn and financing activities.
Given that they have just raised the 7MM last month, this will take them to next inflection and theoretically the beginning of Phase II on Supinoxin and 3117. So no big issues on dilution for now but agreed that is most likely to happen down the line, again nothing unusual for a company going through these stages.
I'd expect a JV or partnering if things get close to the Phase III mark, if the results are very good even an acquisition.
Still a long while to go before then, but seems it'll be ok to ride the wave for now.
GLTA
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM